Vortioxetine overdose in a suicidal attempt: A case report

RATIONALE: Vortioxetine is a new multimodal antidepressant approved by the Food and Drug Administration for the treatment of Major Depressive Disorder and recently introduced in Europe. While antidepressant properties of vortioxetine and its tolerability have been demonstrated by preclinical and cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazza, Mario Gennaro, Rossetti, Aurora, Botti, Eugenia Rossana, Clerici, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023849/
https://www.ncbi.nlm.nih.gov/pubmed/29923970
http://dx.doi.org/10.1097/MD.0000000000010788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023849/
https://www.ncbi.nlm.nih.gov/pubmed/29923970
http://dx.doi.org/10.1097/MD.0000000000010788

Ejemplares similares